The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Endoxana Injection 500 mg Powder for Solution for Injection



Baxter Holding B.V.PA2299/027/001

Main Information

Trade NameEndoxana Injection 500 mg Powder for Solution for Injection
Active SubstancesCyclophosphamide
Dosage FormPowder for solution for injection
Licence HolderBaxter Holding B.V.
Licence NumberPA2299/027/001

Group Information

ATC CodeL01AA Nitrogen mustard analogues
L01AA01 cyclophosphamide

Status

License statusAuthorised
Licence Issued26/06/2008
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back